Back to Search
THOMAS WALSH, M.D.
M.D.
Pulmonary Disease Physician
NPI: 1215074612Individual
Specialties, Licenses & Credentials
Pulmonary Disease PhysicianPrimary
Internal Medicine — Pulmonary Disease
Code: 207RP1001X
D0043029(MD)
Research & Publications (20)
Advances and challenges in infectious diseases supportive care of patients with hematologic malignancies, hematopoietic stem cell transplantation, and severe aplastic anemia.
PMID 19549573·Semin Hematol·2009
8-other
Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial.
PMID 17143808·Clin Infect Dis·2007
3-trial
Control, immunoregulation, and expression of innate pulmonary host defenses against Aspergillus fumigatus.
PMID 16114132·Med Mycol·2005
6-review
Pharmacokinetics and safety of intravenous voriconazole in children after single- or multiple-dose administration.
PMID 15155217·Antimicrob Agents Chemother·2004
3-trial
Infections due to emerging and uncommon medically important fungal pathogens.
PMID 14748802·Clin Microbiol Infect·2004
6-review
Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia.
PMID 15459300·N Engl J Med·2004
3-trial
Experimental pulmonary aspergillosis due to Aspergillus terreus: pathogenesis and treatment of an emerging fungal pathogen resistant to amphotericin B.
PMID 12854088·J Infect Dis·2003
7-preclinical
Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children.
PMID 12005089·Pediatr Infect Dis J·2002
3-trial
Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever.
PMID 11807146·N Engl J Med·2002
3-trial
Overview: non-fumigatus species of Aspergillus: perspectives on emerging pathogens in immunocompromised hosts.
PMID 11890348·Curr Opin Investig Drugs·2001
6-review
Concepts in design of comparative clinical trials of antifungal therapy in neutropenic patients.
PMID 11053799·Int J Antimicrob Agents·2000
6-review
Comparative pharmacodynamic interaction analysis of triple combinations of caspofungin and voriconazole or ravuconazole with subinhibitory concentrations of amphotericin B against Aspergillus spp.
PMID 19389068·Mycoses·2010
8-other
Perceived negative consequences of donor gametes from male and female members of infertile couples.
PMID 19523614·Fertil Steril·2010
4-observational
Taurine attenuates radiation-induced lung fibrosis in C57/Bl6 fibrosis prone mice.
PMID 19609640·Ir J Med Sci·2010
7-preclinical
Fungal biomass is a key factor affecting polymorphonuclear leucocyte-induced hyphal damage of filamentous fungi.
PMID 19638003·Mycoses·2010
8-other
Trichosporon mycotoxinivorans, a novel respiratory pathogen in patients with cystic fibrosis.
PMID 19656976·J Clin Microbiol·2009
5-case
Sexual, marital, and social impact of a man's perceived infertility diagnosis.
PMID 19619144·J Sex Med·2009
8-other
Adverse effect of increased left ventricular wall thickness on five year outcomes of patients with negative dobutamine stress.
PMID 19650895·J Cardiovasc Magn Reson·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2000 DENNIS AVE, SUITE 150
SILVER SPRING, MD 20902 - Phone
- (240) 777-1800
Quick Facts
- NPI
- 1215074612
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile